Clinical Trial Update: Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines whether systemic exposure to atorvastatin and its metabolites is associated with atorvastatin-induced myotoxicity (myop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopathy

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Myopathy | Phase 4 | Status: COMPLETED